First Tracks Biotherapeutics Inc

TRAX | NASDAQ

$44.72

-$0.36 (-0.80%)

Nov 2, 2026, 12:01 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023
Cash & Equivalents	238.2M	123.08M	35.97M
Short-Term Investments	73.44M	262.29M	354.94M
Long-Term Investments	n/a	35.47M	27.03M
Other Long-Term Assets	256K	256K	256K
Receivables	n/a	n/a	n/a
Inventory	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a
Total Current Assets	316.4M	389.93M	398.56M
Property-Plant & Equipment	13.89M	16.23M	18.27M
Goodwill & Intangibles	n/a	n/a	n/a
Total Long-Term Assets	14.15M	51.96M	45.55M
Total Assets	330.55M	441.89M	444.11M
Account Payables	3.11M	3.79M	2.43M
Deferred Revenue	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a
Other Current Liabilities	n/a	7.42M	4.59M
Total Current Liabilities	31.02M	36.18M	18.22M
Long-Term Debt	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a
Total Long-Term Liabilities	12.03M	14.11M	16.04M
Total Liabilities	43.06M	50.3M	34.26M
Total Debt	14.11M	16.04M	17.81M
Book Value	287.49M	391.6M	409.85M
Book Value Per Share	8.27	11.27	11.79
Common Stock	287.51M	391.29M	410.65M
Retained Earnings	n/a	n/a	n/a
Comprehensive Income	-24K	305K	-797K
Shareholders Equity	287.49M	391.6M	409.85M
Total Investments	73.44M	297.76M	381.97M